PLD1 and non-small cell lung carcinoma: Since both radiation and alkylating agents are important as adjuvant therapy for preventing recurrence and metastases in locally advanced non-small cell lung cancer, our results may provide new insights into improving clinical outcomes by targeting the novel ALDOA/PLD1 axis.